360 related articles for article (PubMed ID: 6779243)
1. Cost-benefit analysis of a prenatal preventive programme against congenital syphilis.
Stray-Pedersen B
NIPH Ann; 1980 May; 3(1):57-66. PubMed ID: 6779243
[TBL] [Abstract][Full Text] [Related]
2. [Positive results from serologic screening for syphilis in pregnancy in the Amsterdam region, 1991-1995].
Bont J; Cairo I; van Doornum GJ; Coutinho RA; Bleker OP
Ned Tijdschr Geneeskd; 1999 Nov; 143(46):2312-5. PubMed ID: 10589219
[TBL] [Abstract][Full Text] [Related]
3. Economic evaluation of maternal screening to prevent congenital syphilis.
Stray-Pedersen B
Sex Transm Dis; 1983; 10(4):167-72. PubMed ID: 6665662
[TBL] [Abstract][Full Text] [Related]
4. Congenital syphilis: an economic evaluation of a prevention program in China.
Hong FC; Liu JB; Feng TJ; Liu XL; Pan P; Zhou H; Cai YM; Ling L; Huang XM; Zhang D; Zhang YJ; Zeegers MP
Sex Transm Dis; 2010 Jan; 37(1):26-31. PubMed ID: 19734825
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of on-site antenatal screening to prevent congenital syphilis in rural eastern Cape Province, Republic of South Africa.
Blandford JM; Gift TL; Vasaikar S; Mwesigwa-Kayongo D; Dlali P; Bronzan RN
Sex Transm Dis; 2007 Jul; 34(7 Suppl):S61-6. PubMed ID: 17308502
[TBL] [Abstract][Full Text] [Related]
6. A cost-benefit analysis of California's mandatory premarital screening program for syphilis.
Haskell RJ
West J Med; 1984 Oct; 141(4):538-41. PubMed ID: 6438916
[TBL] [Abstract][Full Text] [Related]
7. [Benefit of the serological screening program for syphilis in pregnant women in Amsterdam in the period 1985-1989].
Bindels PJ; Postma MJ; Peerbooms PG; Coutinho RA; van den Hoek JA
Ned Tijdschr Geneeskd; 1991 Jul; 135(29):1319-22. PubMed ID: 1907721
[TBL] [Abstract][Full Text] [Related]
8. Economic evaluation of preventive programmes against congenital toxoplasmosis.
Stray-Pedersen B; Jenum P
Scand J Infect Dis Suppl; 1992; 84():86-96. PubMed ID: 1290083
[TBL] [Abstract][Full Text] [Related]
9. Economic and programmatic aspects of congenital syphilis prevention.
Schmid G
Bull World Health Organ; 2004 Jun; 82(6):402-9. PubMed ID: 15356931
[TBL] [Abstract][Full Text] [Related]
10. Is antenatal screening for syphilis worth while?
Garland SM; Kelly VN
Med J Aust; 1989 Oct; 151(7):368, 370, 372. PubMed ID: 2507883
[TBL] [Abstract][Full Text] [Related]
11. The prevention and management of congenital syphilis: an overview and recommendations.
Saloojee H; Velaphi S; Goga Y; Afadapa N; Steen R; Lincetto O
Bull World Health Organ; 2004 Jun; 82(6):424-30. PubMed ID: 15356934
[TBL] [Abstract][Full Text] [Related]
12. [Cost-benefit analysis of screening for congenital toxoplasmosis].
Sagmeister M; Gessner U; Kind C; Horisberger B
Schweiz Med Wochenschr Suppl; 1995; 65():103S-112S. PubMed ID: 7716447
[TBL] [Abstract][Full Text] [Related]
13. Economic evaluation of HIV screening in pregnant women attending antenatal clinics in India.
Kumar M; Birch S; Maturana A; Gafni A
Health Policy; 2006 Jul; 77(2):233-43. PubMed ID: 16126300
[TBL] [Abstract][Full Text] [Related]
14. From research to practice: use of short course zidovudine to prevent mother-to-child HIV transmission in the context of routine health care in Northern Thailand.
Thaineua V; Sirinirund P; Tanbanjong A; Lallemant M; Soucat A; Lamboray JL
Southeast Asian J Trop Med Public Health; 1998 Sep; 29(3):429-42. PubMed ID: 10437936
[TBL] [Abstract][Full Text] [Related]
15. Medicaid-based child restraint system disbursement and education and the vaccines for children program: comparative cost-effectiveness.
Goldstein JA; Winston FK; Kallan MJ; Branas CC; Schwartz JS
Ambul Pediatr; 2008; 8(1):58-65. PubMed ID: 18191783
[TBL] [Abstract][Full Text] [Related]
16. Syphilis-associated perinatal and infant mortality in rural Malawi.
McDermott J; Steketee R; Larsen S; Wirima J
Bull World Health Organ; 1993; 71(6):773-80. PubMed ID: 8313495
[TBL] [Abstract][Full Text] [Related]
17. Antenatal syphilis screening in sub-Saharan Africa: lessons learned from Tanzania.
Watson-Jones D; Oliff M; Terris-Prestholt F; Changalucha J; Gumodoka B; Mayaud P; Semakafu AM; Kumaranayake L; Gavyole A; Mabey D; Hayes R
Trop Med Int Health; 2005 Sep; 10(9):934-43. PubMed ID: 16135202
[TBL] [Abstract][Full Text] [Related]
18. Economic evaluation of neonatal screening for phenylketonuria and congenital hypothyroidism.
Geelhoed EA; Lewis B; Hounsome D; O'leary P
J Paediatr Child Health; 2005 Nov; 41(11):575-9. PubMed ID: 16398841
[TBL] [Abstract][Full Text] [Related]
19. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
Hristova L; Hakama M
Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
[TBL] [Abstract][Full Text] [Related]
20. [A cost-benefit evaluation of neonatal screening for phenylketonuria and congenital hypothyroidism].
Gu X; Wang J; Ye J; Cheng X
Zhonghua Yu Fang Yi Xue Za Zhi; 2000 May; 34(3):147-9. PubMed ID: 11860921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
